Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally.
Flawless balance sheet second-rate dividend payer.
Share Price & News
How has Utah Medical Products's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: UTMD has not had significant price volatility in the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: UTMD underperformed the US Medical Equipment industry which returned 20.7% over the past year.
Return vs Market: UTMD underperformed the US Market which returned 19.3% over the past year.
Price Volatility Vs. Market
How volatile is Utah Medical Products's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StWhy Utah Medical Products, Inc. (NASDAQ:UTMD) Should Be In Your Dividend Portfolio
3 weeks ago | Simply Wall StIs Utah Medical Products, Inc.'s (NASDAQ:UTMD) 14% ROE Better Than Average?
1 month ago | Simply Wall StDo Institutions Own Utah Medical Products, Inc. (NASDAQ:UTMD) Shares?
Is Utah Medical Products undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: UTMD ($96.1) is trading above our estimate of fair value ($90.72)
Significantly Below Fair Value: UTMD is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: UTMD is good value based on its PE Ratio (24.4x) compared to the Medical Equipment industry average (47.4x).
PE vs Market: UTMD is poor value based on its PE Ratio (24.4x) compared to the US market (18.5x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate UTMD's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: UTMD is good value based on its PB Ratio (3.5x) compared to the US Medical Equipment industry average (4.1x).
How is Utah Medical Products forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Utah Medical Products has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine Utah Medical Products's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- Explore growth companies in the Healthcare industry.
How has Utah Medical Products performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: UTMD has a high level of non-cash earnings.
Growing Profit Margin: UTMD's current net profit margins (31.4%) are lower than last year (44.2%).
Past Earnings Growth Analysis
Earnings Trend: UTMD's earnings have grown by 6.2% per year over the past 5 years.
Accelerating Growth: UTMD's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: UTMD had negative earnings growth (-20.6%) over the past year, making it difficult to compare to the Medical Equipment industry average (2.7%).
Return on Equity
High ROE: UTMD's Return on Equity (14.6%) is considered low.
Return on Assets
Return on Capital Employed
How is Utah Medical Products's financial position?
Financial Position Analysis
Short Term Liabilities: UTMD's short term assets ($54.9M) exceed its short term liabilities ($3.4M).
Long Term Liabilities: UTMD's short term assets ($54.9M) exceed its long term liabilities ($5.2M).
Debt to Equity History and Analysis
Debt Level: UTMD is debt free.
Reducing Debt: UTMD has no debt compared to 5 years ago when its debt to equity ratio was 7.5%.
Debt Coverage: UTMD has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: UTMD has no debt, therefore coverage of interest payments is not a concern.
Inventory Level: UTMD has a low level of unsold assets or inventory.
Debt Coverage by Assets: UTMD's debt is not covered by short term assets (assets are -1483.4x debt).
What is Utah Medical Products's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Purchase Utah Medical Products before the 'Buy Limit' to receive their next dividend payment.
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: UTMD's dividend (1.17%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.44%).
High Dividend: UTMD's dividend (1.17%) is low compared to the top 25% of dividend payers in the US market (3.71%).
Stability and Growth of Payments
Stable Dividend: UTMD's dividends per share have been stable in the past 10 years.
Growing Dividend: UTMD's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (28.1%), UTMD's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Kevin Cornwell (72yo)
Mr. Kevin L. Cornwell has been the Chairman of the Board at Utah Medical Products Inc. since 1996 and its President and Chief Executive Officer since December 1992. Mr. Cornwell has been Secretary of Utah ...
CEO Compensation Analysis
Compensation vs Market: Kevin's total compensation ($USD501.30K) is below average for companies of similar size in the US market ($USD1.66M).
Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.
|Lead Director||0yrs||US$32.00k||0.27% $961.0k|
|Independent Director||23.1yrs||US$25.00k||0.51% $1.8m|
|Independent Director||13yrs||US$25.00k||0.35% $1.3m|
Experienced Board: UTMD's board of directors are seasoned and experienced ( 22.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: UTMD insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Utah Medical Products, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Utah Medical Products, Inc.
- Ticker: UTMD
- Exchange: NasdaqGS
- Founded: 1978
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: US$357.665m
- Shares outstanding: 3.72m
- Website: https://www.utahmed.com
Number of Employees
- Utah Medical Products, Inc.
- 7043 South 300 West
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|UTMD||NasdaqGS (Nasdaq Global Select)||Yes||Common Stock||US||USD||Dec 1982|
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It also provides umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; MYELO-NATE, a lumbar sampling kit; and HEMO-NATE, a disposable filter. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars and cannulae; Femcare laparoscopic instruments and accessories; and EPITOME, an electrosurgical scalpel. Further, it provides FILSHIE CLIP system, a female surgical contraception; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization; LIBERTY system to treat and control urinary incontinence in women; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other suspected abnormalities of the uterus; and LUMIN to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It markets its products to neonatal intensive care unit, labor and delivery department, women's health center in hospitals, outpatient clinics, and physician's offices. The company sells its products through customer service and sales force, independent consultants, and independent manufacturer representatives. Utah Medical Products, Inc. was founded in 1978 and is headquartered in Midvale, Utah.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/21 00:42|
|End of Day Share Price||2020/02/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.